相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Overview of Development and Formulation of 177Lu-DOTA-TATE for PRRT
Wouter A. P. Breeman et al.
CURRENT RADIOPHARMACEUTICALS (2016)
First evidence of PSMA expression in differentiated thyroid cancer using [68Ga]PSMA-HBED-CC PET/CT
Frederik A. Verburg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Prostate-specific Membrane Antigen-radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer
Tobias Maurer et al.
EUROPEAN UROLOGY (2015)
Beyond 18F-FDG: Characterization of PET/CT and PET/MR Scanners for a Comprehensive Set of Positron Emitters of Growing Application-18F, 11C, 89Zr, 124I, 68Ga, and 90Y
A. Therese Soderlund et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Initial Evaluation of [F-18]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer
Zsolt Szabo et al.
MOLECULAR IMAGING AND BIOLOGY (2015)
Positron-emission tomography in urooncology
T. Maurer et al.
UROLOGE (2015)
Positron-emission tomography in urooncology
T. Maurer et al.
UROLOGE (2015)
Ga-68-PSMA PET/MR with multimodality image analysis for primary prostate cancer
Matthias Eiber et al.
ABDOMINAL IMAGING (2015)
(68)Gallium- and (90)Yttrium-/(177)Lutetium: theranostic twins for diagnosis and treatment of NETs
Rudolf A. Werner et al.
ANNALS OF NUCLEAR MEDICINE (2015)
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience
A. Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
Christian M. Zechmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
How prostate-specific membrane antigen level may be correlated with stemness in prostate cancer stem cell-like cell populations?
Toloudi Maria et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2014)
Cationic eluate pretreatment for automated synthesis of [68Ga]CPCR4.2
Rene Martin et al.
NUCLEAR MEDICINE AND BIOLOGY (2014)
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
A. Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
PET/MR in prostate cancer: technical aspects and potential diagnostic value
Michael Souvatzoglou et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Biodistribution and radiation dosimetry in healthy volunteers of a novel tumour-specific probe for PET/CT imaging: BAY 85-8050
Kamilla Smolarz et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer
Michael Souvatzoglou et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Evaluation of Feasibility and Image Quality of 68Ga-DOTATOC Positron Emission Tomography/Magnetic Resonance in Comparison With Positron Emission Tomography/Computed Tomography in Patients With Neuroendocrine Tumors
Florian C. Gaertner et al.
INVESTIGATIVE RADIOLOGY (2013)
68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
Matthias Eder et al.
BIOCONJUGATE CHEMISTRY (2012)
Biokinetics and dosimetry of 111In-DOTA-NOC-ATE compared with 111In-DTPA-octreotide
Ariane Boubaker et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
RADAR COMMENTARY: USE OF LINEAR NO-THRESHOLD HYPOTHESIS IN RADIATION PROTECTION REGULATION IN THE UNITED STATES
Jeffry A. Siegel et al.
HEALTH PHYSICS (2012)
A Compartmental Model for Biokinetics and Dosimetry of 18F-Choline in Prostate Cancer Patients
Augusto Giussani et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Attenuation correction for PET/MR: Problems, novel approaches and practical solutions
Axel Martinez-Moeller et al.
ZEITSCHRIFT FUR MEDIZINISCHE PHYSIK (2012)
A dimerized urea-based inhibitor of the prostate-specific membrane antigen for Ga-68-PET imaging of prostate cancer
Martin Schaefer et al.
EJNMMI RESEARCH (2012)
Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET
Johannes Notni et al.
EJNMMI RESEARCH (2012)
Three Methods Assessing Red Marrow Dosimetry in Lymphoma Patients Treated With Radioimmunotherapy
Ludovic Ferrer et al.
CANCER (2010)
Biodistribution and radiation dosimetry of [11C]choline: a comparison between rat and human data
Tuula Tolvanen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques
Matthias Hofmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant Metastasis
Sebastian Mannweiler et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Technology Insight: monoclonal antibody imaging of prostate cancer
NH Bander
NATURE CLINICAL PRACTICE UROLOGY (2006)
分享论文
